Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv
Everyone loves talking about obesity medicines, so let’s talk about obesity medicine. By taking Friday off, I didn’t get a chance to highlight the news that CMS will -- officially
Programming note: No Curve tomorrow. Back Monday. Behave, y’all. We’re in the thick of earnings season, and we had quarterly numbers drop today from Sanofi, AstraZeneca, AbbVie, and Roche. All